Investor Panel: Funding Retinal Innovation — Strategies to Advance Dry AMD & GA Therapies from Discovery to Clinic
Time: 1:45 pm
day: Day2
Details:
- Explore how investors evaluate early-stage retinal programs with novel mechanisms targeting dry AMD and GA
- Discuss key data inflection points (preclinical validation, safety studies, early efficacy signals, regulatory alignment) that attract venture and institutional funding
- Review challenges specific to funding AMD programs including long development timelines, endpoint complexity, and patient heterogeneity
